Work

Supplementary Figure S8 from Phase Ib Clinical and Pharmacodynamic Study of the TIE2 Kinase Inhibitor Rebastinib with Paclitaxel or Eribulin in HER2-Negative Metastatic Breast Cancer

Year: 2025

Type: supplementary-materials

Abstract: Supplementary Figure S8 shows the effect of chemotherapy or rebastinib on TIE2 monocytes. A, Trends in TIE2 monocytes with rebastinib and rebastinib plus chemotherapy; B, trends in TIE2 monocytes with chemotherapy and rebastinib plus chemotherapy. Each line represent data from one patient over time. Abbreviations: C, Cycle; D, Day.

DOI: 10.1158/1078-0432.28227602

Authors: Jesus D. Anampa, Daniel L. Flynn, Cynthia Leary, Sun Oh, Xiaonan Xue, Maja H. Oktay, John S. Condeelis, Joseph A. Sparano

Language: English

Topic: Angiogenesis and VEGF in Cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4406541557

Cites:

Cited by:

Related to: 10